Quick Answer
L-Glutamine Gut Health Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) were calculated.
Key Takeaways
- 01Risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) were calculated. [Zhang Y (2026)]
- 02Moreover, immunonutrition reduced the incidence of overall postoperative complications (RR 0.64, 95% CI 0.55, 0.75) and postoperative abdominal distension (RR 0.33, 95% CI 0.12, 0.89). [Zhang Y (2026)]
- 03Conclusion Perioperative immunonutrition supplementation significantly shortened the time to first flatus and time to first defecation after colorectal cancer surgery. [Zhang Y (2026)]
- 04Objective The effect of immunonutrition on postoperative gastrointestinal recovery in patients undergoing colorectal cancer surgery remains controversial. [Zhang Y (2026)]
The current Migaku evidence database contains 2 reusable source documents for L-Glutamine Gut Health Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) were calculated. [Zhang Y (2026); evidence level 1]
- Moreover, immunonutrition reduced the incidence of overall postoperative complications (RR 0.64, 95% CI 0.55, 0.75) and postoperative abdominal distension (RR 0.33, 95% CI 0.12, 0.89). [Zhang Y (2026); evidence level 1]
- Conclusion Perioperative immunonutrition supplementation significantly shortened the time to first flatus and time to first defecation after colorectal cancer surgery. [Zhang Y (2026); evidence level 1]
- Objective The effect of immunonutrition on postoperative gastrointestinal recovery in patients undergoing colorectal cancer surgery remains controversial. [Zhang Y (2026); evidence level 1]
- High-protein diets have dual effects on metabolic dysfunction-associated steatotic liver disease, depending on protein source and amount. [Yin Hong-Yuan (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources